Actively Recruiting
An Extension to Assess the Effect of Expanded Dialysis on Patient Reported Symptoms Using LEVIL
Led by London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's · Updated on 2026-05-04
100
Participants Needed
4
Research Sites
147 weeks
Total Duration
On this page
Sponsors
L
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Lead Sponsor
B
Baxter Healthcare Corporation
Collaborating Sponsor
AI-Summary
What this Trial Is About
Investigators know that many patients who are on dialysis suffer from burden of unwanted symptoms, which can affect quality of life. The understanding and treatment of symptom burden by healthcare providers is limited and should be recognized as a high priority in the care of the dialysis population. In this study, the investigators will be assessing symptom burden using the London Evaluation of Illness "LEVIL," an application based platform where patients self-report their symptoms with one to three hemodialysis treatments per week for 28 weeks. The investigators would like to compare the currently available dialyzer with a new dialyzer that is capable of removing solutes of higher molecular weight that may or may not cause patients to experience symptoms related to increased amounts of toxins in their blood.
CONDITIONS
Official Title
An Extension to Assess the Effect of Expanded Dialysis on Patient Reported Symptoms Using LEVIL
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Conventional thrice weekly HD schedule
- Must be on chronic hemodialysis for at least 3 months
- Age 2518 years
- Willing and able to give informed consent
You will not qualify if you...
- Active infection (may enroll once infection is cleared)
- Patients receiving daily hemodialysis treatment
- Patients currently receiving Hemodiafiltration (HDF), Hemofiltration (HF) or Isolated ultrafiltration (ISO UF) more than once in three months
- Visual impairment
- History of neurocognitive impairment
- History of stroke (CVA)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 4 locations
1
Seven Oaks Hospital Chronic Disease Innovation Centre Inc. (CDIC)
Winnipeg, Manitoba, Canada, R2V 3M3
Actively Recruiting
2
QEII Health Sciences Centre, Nova Scotia Health
Halifax, Nova Scotia, Canada, B3H 1V7
Actively Recruiting
3
Victoria Hospital, London Health Sciences Centre
London, Ontario, Canada, N6A 5W9
Actively Recruiting
4
Westmount Kidney Care Centre
London, Ontario, Canada, N6K 1M6
Actively Recruiting
Research Team
C
Christopher McIntyre, MBBS DM
CONTACT
J
Jarrin Penny, PHD RN CNeph
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here